The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Value Is Anticipated For The Hydroxychloroquine Market Over The Period 2026–2030?
The hydroxychloroquine market has experienced significant expansion in recent years. It is anticipated to grow from $2.38 billion in 2025 to $2.52 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.2%. This historical growth can be linked to the considerable prevalence of malaria in endemic areas, its recognized application in autoimmune disorders, increasing public awareness of hydroxychloroquine’s advantages, its accessibility through hospital and retail pharmacies, and the rising clinical adoption for conditions such as rheumatoid arthritis and lupus.
The hydroxychloroquine market size is anticipated to undergo significant expansion in the coming years. It is projected to grow to $3.26 billion in 2030, driven by a compound annual growth rate (CAGR) of 6.6%. This expected growth over the forecast period stems from ongoing research into COVID-19 applications, the creation of novel formulations and delivery methods, the widening reach of online pharmacy channels, escalating government health initiatives for malaria prevention, and increasing investments in clinical trials and off-label studies. Prominent trends for the forecast period encompass the rising application of hydroxychloroquine for both malaria prevention and treatment, its growing acceptance in the management of rheumatoid arthritis and lupus, an increase in off-label uses and clinical research for COVID-19, the diversification of tablet formulations and injectable variants, and its enhanced distribution through hospital, online, and retail pharmacies.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3235&type=smp
What Drivers Are Expected To Influence The Hydroxychloroquine Market During The Forecast Period?
The increasing incidence of rheumatoid arthritis is predicted to fuel the expansion of the hydroxychloroquine market. Rheumatoid arthritis is an autoimmune and inflammatory ailment where the immune system mistakenly attacks healthy cells, causing inflammation in affected areas of the body. Hydroxychloroquine is valuable in treating rheumatoid arthritis as it helps mitigate inflammation and relieve symptoms, thus enhancing the quality of life for numerous patients. For example, in June 2023, data from the Centers for Disease Control and Prevention, a US-based health protection agency, revealed that 54.4 million adults in the United States had been diagnosed with arthritis, a figure projected to rise to 78 million by 2040. Consequently, the rising number of rheumatoid arthritis cases is anticipated to stimulate the hydroxychloroquine market. Hydroxychloroquine Market Driver: Impact Of Rising Healthcare Expenditure On The Growth Of The Hydroxychloroquine Market
How Is The Hydroxychloroquine Market Divided Into Its Major Segments?
The hydroxychloroquine market covered in this report is segmented –
1) By Drug Activity: Anti-Malarial Drug, Anti-Rheumatic Drug, Lupus Suppressant Drug, Anti COVID-19 Drug, Other Drug Activity
2) By Formulation: Tablets, Injection
3) By Application: Malaria, Rheumatoid Arthritis, Lupus Erythematosus, COVID-19, Other Applications
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Specialty Drug Stores, Retail Pharmacy
Subsegments:
1) By Anti-Malarial Drug: Treatment Of Malaria, Prophylaxis For Malaria
2) By Anti-Rheumatic Drug: Treatment Of Rheumatoid Arthritis, Treatment Of Juvenile Idiopathic Arthritis
3) By Lupus Suppressant Drug: Treatment Of Systemic Lupus Erythematosus
4) By Anti COVID-19 Drug: Treatment Of COVID-19 Symptoms
5) By Other Drug Activity: Treatment Of Other Autoimmune Disorders, Additional Off-label uses
Who Are The Prominent Organizations Shaping The Hydroxychloroquine Market?
Major companies operating in the hydroxychloroquine market are Bayer AG, Dr. Reddy’s Laboratories Ltd., Zydus Group, Ipca Laboratories Ltd., Wallace Pharma, Teva Pharmaceuticals Inc., Mylan Pharmaceuticals Inc., Novartis AG, Intas Pharmaceuticals Ltd., Lupin Limited, Shanghai Zhongxi Sanwei Pharmaceutical Co. Ltd., Torrent Pharmaceuticals Ltd., Hikma Pharmaceuticals plc, Sandoz International GmbH, Cipla Limited, Shenhua Pharmaceutical Co. Ltd., Sanofi S.A., Macleod Pharmaceuticals Ltd., Laurus Labs, TAJ Pharmaceuticals, Wuhan Wuyao Pharmaceutical Co. Ltd., Concordia Healthcare, Pfizer Inc., Cadila Pharmaceuticals, Hetero Drugs Ltd., Jubilant Generics Limited, Alembic Pharmaceuticals Limited, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma USA Inc., Alkem Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Unichem Laboratories Ltd., Wockhardt Limited, Emcure Pharmaceuticals Ltd., Strides Pharma Science Ltd., Indoco Remedies Ltd.
Read the full hydroxychloroquine market report here:
https://www.thebusinessresearchcompany.com/report/hydroxychloroquines-global-market-report
Which Region Is Forecast To Lead The Hydroxychloroquine Market In Terms Of Market Size?
North America was the largest region in the hydroxychloroquine market in 2025. Middle East is expected to be the fastest-growing region in the hydroxychloroquine market report. The regions covered in the hydroxychloroquine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Hydroxychloroquine Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=3235&type=smp
Browse Through More Reports Similar to the Global Hydroxychloroquine Market 2026, By The Business Research Company
Cardiovascular Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/cardiovascular-drugs-global-market-report
Dermatology Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/dermatology-drugs-global-market-report
Gastrointestinal Drug Market Report 2026
https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model